Skip to main content
Michael Debaun, MD, Pediatric Hematology & Oncology, Nashville, TN, Monroe Carell Jr. Childrens Hospital

MichaelRDebaunMDMPH

Pediatric Hematology & Oncology Nashville, TN

Pediatric Anemia and Red Blood Cell Hematology

Professor, Pediatrics, Vanderbilt University School of Medicine

Dr. Debaun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Debaun's full profile

Already have an account?

Summary

  • Dr. Michael Debaun is a pediatric hematologist/oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Monroe Carell Jr. Childrens Hospital and Vanderbilt University Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 30 years. He specializes in pediatric anemia and red blood cell hematology.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1990 - 1993
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1987 - 1990
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1987

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2011 - 2026
  • FL State Medical License
    FL State Medical License 2013 - 2020
  • MD State Medical License
    MD State Medical License 1992 - 2010
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Silent Infarcts in Sickle Cell Anemia Occur in the Borderzone Region and Are Associated with Low Cerebral Blood Flow  
    Lori C Jordan, Andria L Ford, Melanie E Fields, Robert C McKinstry, Michael R DeBaun, Blood
  • Pregnancy Outcomes in Women with Sickle‐Cell Disease in Low and High Income Countries: A Systematic Review and Meta‐Analysis  
    Michael R DeBaun, M H Aliyu, M G Tuuli, BJOG: An International Journal of Obstetrics & Gynaecology

Abstracts/Posters

  • Sickle Cell Disease Post-Transplant Care Challenges in Nigeria: Systematic Institutional Neglect of Medical Tourism
    Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis
    Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • High Levels of Peripheral Vasoconstriction Detected By Polysomnography Predict More Acute Severe Pain Episodes in Children with Sickle Cell Anemia
    Michael R. DeBaun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Pediatric Clinical Non-Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Pediatric Clinical Non-Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • ASH Clinical Practice Guidelines on Sickle Cell Disease 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Join now to see all

Other

Press Mentions

  • Easing the Toll of Sickle Cell Disease in Childbirth
    Easing the Toll of Sickle Cell Disease in ChildbirthJanuary 2nd, 2017
  • Vanderbilt Establishes Recruitment Innovation Center to Increase Enrollment of Minorities, Women and Older Adults in Clinical Trials
    Vanderbilt Establishes Recruitment Innovation Center to Increase Enrollment of Minorities, Women and Older Adults in Clinical TrialsJuly 5th, 2016
  • Does Our Healthcare System Abandon Adult Sickle Cell Patients?
    Does Our Healthcare System Abandon Adult Sickle Cell Patients?March 22nd, 2016
  • Join now to see all

Grant Support

  • Hydroxyurea To Prevent CNS Complications Of Sickle Cell Disease In ChildrenNational Heart, Lung, And Blood Institute2011
  • Asthma And Nocturnal Hypoxemia In Sickle Cell Anemia IINational Heart, Lung, And Blood Institute2011
  • Asthma And Nocturnal Hypoxemia In Sickle Cell Anemia IINational Heart, Lung, And Blood Institute2010
  • Silent Cerebral Infarct Multi-Center Clinical TrialNational Institute Of Neurological Disorders And Stroke2003–2010
  • 2009 Clinical Research Training Institute Summer WorkshopNational Heart, Lung, And Blood Institute2009
  • Asthma And Nocturnal Hypoxemia In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2005–2008
  • Asthma And Nocturnal Hypoxemia In Sickle Cell AnemiaNational Center For Research Resources2007
  • Screening And Treatment Of Silent Infarcts For Children With Sickle Cell DISENational Center For Research Resources2005–2006
  • Importance Of Hemodynamic Factors In The Prognosis Of Stroke In Sickle CellNational Center For Research Resources2005–2006
  • Importance Of Hemodynamic Factors In The Prognosis Of Stroke In Patient With SCDNational Center For Research Resources2005–2006
  • Increasing Blood And Cord Blood Donation In BlacksNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
  • Feasibility, Safety And Short-Term Efficacy Of Prolonged Ganciclovir ProphylaxisNational Center For Research Resources2004–2005
  • Pediatric Oncology GroupNational Cancer Institute1997–1999

Hospital Affiliations